This is a preview of subscription content, log in via an institution to check access.
Access this chapter
Tax calculation will be finalised at checkout
Purchases are for personal use only
Similar content being viewed by others
References
Aguilar MI, Hart RG, Kase CS, Freeman WD, Hoeben BJ, Garcia RC, Ansell JE, Mayer SA, Norrving B, Rosand J, Steiner T, Wijdicks EFM, Yamaguchi T, Yasaka M. Treatment of warfarin-associated intracerebral hemorrhage: literature review and expert opinion. Mayo Clin Proc. 2007;82:82–92.
Ansell J, Hirsch J, Hylek E, Jacobson A, Crowther M, Palareti G. Pharmacology and management of the vitamin K antagonists: American College of Chest Physicians evidence-based clinical practice guidelines (8th ed.). Chest. 2008;133:160S–98S.
Baron TH, Kamath PS, McBane RD. Management of antithrombotic therapy in patients undergoing invasive procedures. N Engl J Med. 2013;368:2113–24.
Bijsterveld NR, Moons AH, Boekholdt SM, van Aken BE, Fennema H, Peters RJ, Meijers JC, Buller HR, Levi M. Ability of recombinant factor VIIa to reverse the anticoagulant effect of the pentasaccharide fondaparinux in healthy volunteers. Circulation. 2002;106:2550–4.
Bülent Ö, Madhvi R, Lusher JM. How do you treat bleeding disorders with desmopressin? Postgrad Med J. 2007;83:159–63.
Bux J. Transfusion-related acute lung injury (TRALI): a serious adverse event of blood transfusion. Vox Sang. 2005;89:1–10.
Cattaneo M. Advances in antiplatelet therapy: overview of new P2Y12 receptor antagonists in development. Eur Heart J Suppl. 2008;10(Suppl I):I 33–7.
Colucci G, Stutz M, Rochat S, Conte T, Pavicic M, Reusser M, Giabbani E, Huynh A, Thürlemann C, Keller P, Alberio L. The effect of desmopressin on platelet function: a selective enhancement of procoagulant COAT platelets in patients with primary platelet function defects. Blood. 2014;123:1905–16.
Crockett MT, Moynagh MR, Kavanagh EC. The novel oral anticoagulants: an update for the interventional radiologist. AJR Am J Roentgenol. 2012;199[web]:W 376–9.
Desmurs-Clavel H, Huchon C, Chatard B, Negrier C, Dargaud Y. Reversal of the inhibitory effect of fondaparinux on thrombin generation by rFVIIa, aCCP and PCC. Thromb Res. 2009;123:796–8.
Diener H-C, Cunha L, Ce F, Sivenius J, Smets P, Lowenthal A. European Stroke Prevention Study 2: dipyridamole and acetylsalicylic acid in the secondary prevention of stroke. J Neurol Sci. 1996;143:1–13.
Douketis JD, Spyropoulos AC, Spencer FA, Mayr M, Ak J, Eckman MH, Dunn AS, Kunz R. Perioperative Management of Antithrombotic Therapy. Antithrombotic Therapy and Prevention of Thrombosis, 9th ed: American College of Chest Physicians evidence-based clinical practice guidelines. Chest. 2012;11:e326S–50S.
Hall R, Mazer CD. Antiplatelet drugs: a review of their pharmacology and management in the perioperative period. Anesth Analg. 2011;112:292–318.
Hunt BJ. Bleeding and coagulopathies in critical care. N Engl J Med. 2014;370:847–59.
Hursting MJ, Lewis BE, Macfarlane DE. Transitioning from argatroban to warfarin therapy in patients with heparin-induced thrombocytopenia. Clin Appl Thromb Hemost. 2005;11:279–87.
Jaffe T, Raiff D, Ho L, Kim C. Management of anticoagulant and antiplatelet medications in adults undergoing percutaneous interventions. AJR Am J Roentgenol. 2015;205:421–8.
Jneid H, Anderson JL, Wright RS, Adams CD, Bridges CR, Casey Jr DE, Ettinger SM, Fesmire FM, Ganiats TG, Am L, Peterson ED, Philippides GJ, Theroux P, Wenger NK, Zidar JP. 2012 ACC/AHA focused update of the guideline for the management of patients with unstable angina/non-ST-elevation myocardial infarction (updating the 2007 guideline and replacing the 2011 focused update). J Am Coll Cardiol. 2012;60:645–81.
Khan H, Belsher J, Yilmaz M, Afessa B, Winters JL, Moore SB, Hubmayr RD, Gajic O. Fresh-frozen plasma and platelet transfusions are associated with development of acute lung injury in critically ill medical patients. Chest. 2007;131:1308–14.
Kohi MP, Fidelman N, Behr S, Taylor AG, Kolli K, Conrad M, Hwang G, Weinstein S. Periprocedural patient care. Radiographics. 2015;35:1766–78.
Layton KF, Kallmes DF, Horlocker TT. Recommendations for anticoagulated patients undergoing image-guided spinal procedures. AJNR Am J Neuroradiol. 2006;27:467–71.
Lazo-Langner A, Lang ES, Douketis J. Clinical management of new oral anticoagulants: a structured review with emphasis on the reversal of bleeding complications. Crit Care. 2013;17:230–242
Lee SB, Manno EM, Layton KF, Wijdicks EF. Progression of warfarin-associated intracerebral hemorrhage after INR normalization with FFP. Neurology. 2006;67:1272–4.
Levi M, Vink R, de Jonge E. Prevention and treatment of bleeding by pro-hemostatic treatment strategies. Wien Med Wochenschr. 2003;153:421–5.
Lexicomp Online. Oral anticoagulant comparison chart. Lexi-Comp: Hudson; 2014a.
Lexicomp Online. Prothrombin complex concentrate (human) (factors II, VII, IX, X), protein C and protein S. Lexi-Comp: Hudson; 2014b.
Lexicomp Online. Dabigtran Etexilate (Lexi-Drug). Lexi-Comp: Hudson; 2014c.
Lexicomp Online. Cilostazol (Lexi-Drug). Lexi-Comp: Hudson; 2014d.
Makris M, Greaves M, Phillips WS, Kitchen S, Rosendaal FR, Preston EF. Emergency oral anticoagulant reversal: the relative efficacy of infusions of fresh frozen plasma and clotting factor concentrate on correction of the coagulopathy. Thromb Haemost. 1997;77:477–80.
Makris M, Watson HG. The management of coumarin-induced over-anticoagulation Annotation. Br J Haematol. 2001;114:271–80.
Mannucci PM, Aberg M, Nilsson IM, Robertson B. Mechanism of plasminogen activator and factor VIII increase after vasoactive drugs. Br J Haematol. 1975;30:81–93.
McCoy CC, Lawson JH, Shapiro ML. Management of anticoagulation agents in trauma patients. Clin Lab Med 2014;34:563–74 27.
Narouze S, Benzon HT, Provenzano DA, Buvanendran A, De Andres J, Deer TR, Rauck R, Huntoon MA. Interventional Spine and Pain Procedures in Patients on Antiplatelet and Anticoagulant Medications. Guidelines from the American Society of Regional Anesthesia and Pain Medicine, the European Society of Regional Anaesthesia and Pain Therapy, the American Academy of Pain Medicine, the International Neuromodulation Society, the North American Neuromodulation Society, and the World Institute of Pain. Regional Anesthesia Pain Med. 2015;40:182–212.
Patel IJ, Davidson JC, Nikolic B, Salazar GM, Schwartzberg MS, Walker TG, Saad WE. Consensus guidelines for periprocedural management of coagulation status and hemostasis risk in percutaneous image-guided interventions. J Vasc Interv Radiol. 2012;23:727–36.
Patel IJ, Davidson JC, Nikolic B, Salazar GM, Schwartzberg MS, Walker TG, Saad WE. Addendum of newer anticoagulants to the SIR consensus guideline. J Vasc Interv Radiol. 2013;24:641–5.
Stangier J, Rathgen K, Stahle H, Gansser D, Roth W. The pharmacokinetics, pharmacodynamics and tolerability of dabigatran etexilate, a new oral direct thrombin inhibitor, in healthy male subjects. Br J Clin Pharmacol. 2007;64:292–303.
Yorkgitis BK, Ruggia-Check C, Dujon JE. Antiplatelet and anticoagulation medications and the surgical patient. Am J Surg. 2014;207:95–101.
Vanermeulen EP, Van Aken H, Vermylen J. Anticoagulants and spinal-epidural anesthesia. Anesth Analg. 1994;79:1165–77.
Wun T, Paglieroni TG, Lachant NA. Desmopressin stimulates the expression of P-selectin on human platelets in vitro. J Lab Clin Med. 1995;126:401–9.
Zareh M, Davis A, Henderson S. Reversal of warfarin-induced hemorrhage in the emergency department. West J Emerg Med. 2011;12:386–92.
Author information
Authors and Affiliations
Rights and permissions
Copyright information
© 2017 Springer International Publishing Switzerland
About this chapter
Cite this chapter
Hon, M., Silbergleit, R., Ortiz, A.O. (2017). Anticoagulation Management. In: Image-Guided Percutaneous Spine Biopsy. Springer, Cham. https://doi.org/10.1007/978-3-319-43326-4_2
Download citation
DOI: https://doi.org/10.1007/978-3-319-43326-4_2
Published:
Publisher Name: Springer, Cham
Print ISBN: 978-3-319-43324-0
Online ISBN: 978-3-319-43326-4
eBook Packages: MedicineMedicine (R0)